MWA
TMO icon

Meridian Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Meridian Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.69M Buy
9,351
+8,055
+622% +$3.87M 0.53% 47
2026
Q1 		$637K Sell
1,296
-39
-3% -$21.2K 0.08% 122
2025
Q4 		$774K Hold
1,335
– – 0.11% 103
2025
Q3 		$648K Hold
1,335
– – 0.09% 110
2025
Q2 		$541K Sell
1,335
-59
-4% -$24.7K 0.09% 118
2025
Q1 		$694K Sell
1,394
-260
-16% -$141K 0.12% 92
2024
Q4 		$861K Hold
1,654
– – 0.14% 85
2024
Q3 		$1.02M Sell
1,654
-7
-0.4% -$4.14K 0.17% 79
2024
Q2 		$919K Buy
1,661
+7
+0.4% +$4.01K 0.16% 85
2024
Q1 		$961K Hold
1,654
– – 0.18% 84
2023
Q4 		$878K Hold
1,654
– – 0.19% 84
2023
Q3 		$837K Buy
1,654
+40
+2% +$21.3K 0.21% 82
2023
Q2 		$842K Hold
1,614
– – 0.2% 82
2023
Q1 		$930K Hold
1,614
– – 0.23% 80
2022
Q4 		$889K Sell
1,614
-133
-8% -$70.5K 0.23% 81
2022
Q3 		$886K Buy
1,747
+1
+0.1% +$560 0.25% 77
2022
Q2 		$949K Buy
1,746
+623
+55% +$343K 0.25% 80
2022
Q1 		$664K Buy
1,123
+643
+134% +$369K 0.15% 111
2021
Q4 		$321K Buy
480
+7
+1% +$4.37K 0.08% 156
2021
Q3 		$270K Hold
473
– – 0.08% 163
2021
Q2 		$239K Sell
473
-43
-8% -$20.3K 0.07% 177
2021
Q1 		$236K Sell
516
-1,520
-75% -$725K 0.08% 159
2020
Q4 		$948K Sell
2,036
-10
-0.5% -$4.69K 0.35% 66
2020
Q3 		$903K Sell
2,046
-90
-4% -$37.2K 0.39% 58
2020
Q2 		$774K Buy
2,136
+384
+22% +$129K 0.36% 63
2020
Q1 		$497K Buy
1,752
+186
+12% +$58.7K 0.27% 74
2019
Q4 		$509K Buy
1,566
+13
+0.8% +$3.94K 0.2% 92
2019
Q3 		$452K Buy
+1,553
New +$445K 0.19% 98
2019
Q1 		– Sell
-53
Closed -$12K – 363
2018
Q4 		$12K Buy
+53
New +$12.4K 0.01% 392

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Meridian Wealth Advisors's TMO Position: Q2 2026 in Review

Meridian Wealth Advisors increased its Thermo Fisher Scientific (TMO) stake by 622% in Q2 2026, buying an estimated $3.87M and bringing the position to 9,351 shares worth $4.69M. The position accounts for 0.53% of the portfolio, ranked #47.

Meridian Wealth Advisors first reported a position in TMO in Q4 2018 and has held it in 29 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Meridian Wealth Advisors held 9,351 shares of Thermo Fisher Scientific worth $4.69M as of Q2 2026.
  • Meridian Wealth Advisors bought 8,055 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.87M.
  • Thermo Fisher Scientific made up 0.53% of Meridian Wealth Advisors's portfolio in Q2 2026, its #47 holding.
  • Meridian Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 29 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Meridian Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.